Datasets for the effects of RUNX2 silencing on transcriptomic and metabolomic profiles in SJSA-1 osteosarcoma cells
Osteosarcoma is the most common primary malignant bone tumor with a high JOINT PAIN RELIEF risk of metastasis and recurrence.Metabolic reprogramming is a hallmark of osteosarcoma and other cancers and is associated with genetic and epigenetic alterations.RUNX2 is an important transcription factor for osteoblastic differentiation, and aberrant expre